SCHEMBL6978633

SCHEMBL6978633

CCOC(=O)CN(c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C(=N)NC(=O)OCC)cc1)S(=O)(=O)c1cccc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.36
PARP1 P09874 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
NR3C1 P04150 2/20 0.35
POLB P06746 2/20 0.34
ALDH1A1 P00352 3/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
NOTUM Q6P988 1/20 0.34
TSHR P16473 1/20 0.33
THRB P10828 2/20 0.33
MAPT P10636 2/20 0.33
NPY5R Q15761 1/20 0.33
IDO1 P14902 1/20 0.33
KCNH2 Q12809 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089638 0.96 PARP1 (0.36) RORCPARP1PDK1PDK2PDK3
Hydrochloric Acid SCHEMBL6979622 0.90 F2 (0.39) RORCPARP1PDK1PDK2PDK3
SCHEMBL6984478 0.88 F2 (0.42) PDK1PDK2PDK3PDK4POLB
SCHEMBL6979171 0.88 USP2 (0.41) PDK1PDK2PDK3PDK4NR3C1
SCHEMBL7085092 0.86 ALDH1A1 (0.39) RORCPARP1NR3C1ALDH1A1LMNA
SCHEMBL6984183 0.85 F2 (0.40) PDK1PDK2PDK3PDK4NR3C1
SCHEMBL7088163 0.84 PARP1 (0.37) PARP1NR3C1ALDH1A1LMNAHPGD
SCHEMBL6984844 0.84 USP2 (0.39) PDK1PDK2PDK3PDK4NR3C1
Iodide SCHEMBL7956718 0.84 F2 (0.39) RORCPARP1PDK1PDK2PDK3
SCHEMBL7960542 0.83 F2 (0.41) PARP1PDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed